188 related articles for article (PubMed ID: 22833242)
21. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry.
Nuño-Nuño L; Joven BE; Carreira PE; Maldonado-Romero V; Larena-Grijalba C; Llorente Cubas I; Tomero E; Barbadillo-Mateos MC; García de la Peña Lefebvre P; Ruiz-Gutiérrez L; López-Robledillo JC; Moruno-Cruz H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; García de Yébenes MJ; López-Longo FJ
Int J Rheum Dis; 2019 Aug; 22(8):1393-1401. PubMed ID: 30968571
[TBL] [Abstract][Full Text] [Related]
22. Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis.
Smoyer-Tomic KE; Amato AA; Fernandes AW
BMC Musculoskelet Disord; 2012 Jun; 13():103. PubMed ID: 22703603
[TBL] [Abstract][Full Text] [Related]
23. Necrotizing myopathy: clinicoserologic associations.
Ellis E; Ann Tan J; Lester S; Tucker G; Blumbergs P; Roberts-Thomson P; Limaye V
Muscle Nerve; 2012 Feb; 45(2):189-94. PubMed ID: 22246873
[TBL] [Abstract][Full Text] [Related]
24. Malignancy in myositis.
Zahr ZA; Baer AN
Curr Rheumatol Rep; 2011 Jun; 13(3):208-15. PubMed ID: 21336621
[TBL] [Abstract][Full Text] [Related]
25. Acute Coronary Syndrome in Idiopathic Inflammatory Myopathies: A Population-based Study.
Leclair V; Svensson J; Lundberg IE; Holmqvist M
J Rheumatol; 2019 Nov; 46(11):1509-1514. PubMed ID: 30877220
[TBL] [Abstract][Full Text] [Related]
26. [Epidemiology of idiopathic inflammatory myopathy in Hungary].
Nagy-Vincze M; Bodoki L; Griger Z; Dankó K
Orv Hetil; 2014 Oct; 155(41):1643-6. PubMed ID: 25282109
[TBL] [Abstract][Full Text] [Related]
27. Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset.
Antovic A; Notarnicola A; Svensson J; Lundberg IE; Holmqvist M
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1849-1855. PubMed ID: 29579357
[TBL] [Abstract][Full Text] [Related]
28. Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database.
Albrecht K; Huscher D; Callhoff J; Richter JG; Alexander T; Henes J; Zink A
Rheumatol Int; 2020 Oct; 40(10):1639-1647. PubMed ID: 32594219
[TBL] [Abstract][Full Text] [Related]
29. The risk of cancer in patients with connective tissue diseases but without dermatomyositis or polymyositis: A multicenter cohort study conducted over 15 years in China.
Xu W; Guo H; Liu Z; Chen C; Lei CC
Immunol Lett; 2016 Sep; 177():70-4. PubMed ID: 27474413
[TBL] [Abstract][Full Text] [Related]
30. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
[TBL] [Abstract][Full Text] [Related]
31. Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.
Gupta L; Naveen R; Gaur P; Agarwal V; Aggarwal R
Semin Arthritis Rheum; 2021 Feb; 51(1):113-120. PubMed ID: 33360322
[TBL] [Abstract][Full Text] [Related]
32. Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis.
Nuño L; Joven B; Carreira P; Maldonado V; Larena C; Llorente I; Tomero E; Barbadillo MC; García-de la Peña P; Ruiz L; López-Robledillo JC; Moruno H; Pérez A; Cobo-Ibáñez T; Almodóvar R; Lojo L; Monteagudo I; García-De Yébenes MJ; López-Longo FJ
Reumatol Clin; 2017; 13(6):331-337. PubMed ID: 27616211
[TBL] [Abstract][Full Text] [Related]
33. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
[TBL] [Abstract][Full Text] [Related]
34. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
[TBL] [Abstract][Full Text] [Related]
35. High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.
Nakajima A; Yoshino K; Soejima M; Kawaguchi Y; Satoh T; Kuwana M; Yamanaka H
Rheumatol Int; 2012 Jul; 32(7):2057-61. PubMed ID: 21479881
[TBL] [Abstract][Full Text] [Related]
36. A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.
Limaye VS; Lester S; Bardy P; Thompson P; Cox S; Blumbergs P; Roberts-Thomson P
Rheumatol Int; 2012 Mar; 32(3):611-9. PubMed ID: 21125283
[TBL] [Abstract][Full Text] [Related]
37. Incidence of malignancies in biopsy-proven inflammatory myopathy.
Kannan MA; Sundaram C; Uppin M; Mridula R; Jabeen SA; Borgohain R
Neurol India; 2013; 61(2):152-5. PubMed ID: 23644314
[TBL] [Abstract][Full Text] [Related]
38. Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality.
Sultan SM; Ioannou Y; Moss K; Isenberg DA
Rheumatology (Oxford); 2002 Jan; 41(1):22-6. PubMed ID: 11792875
[TBL] [Abstract][Full Text] [Related]
39. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
40. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
